{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:10:55Z","timestamp":1780341055273,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03098-7","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T13:01:57Z","timestamp":1716642117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Monoclonal gammopathy in the setting of Pyoderma gangrenosum"],"prefix":"10.1007","volume":"316","author":[{"given":"Vahide","family":"Saeidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Garimella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Shaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Denis P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Dutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"issue":"4","key":"3098_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1001\/archderm.1930.01440160053009","volume":"22","author":"LA Brunsting","year":"1930","unstructured":"Brunsting LA, Goeckerman WH, O\u2019Leary PA (1930) Pyoderma (echthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syphilol 22(4):655\u2013680","journal-title":"Arch Dermatol Syphilol"},{"issue":"3","key":"3098_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1365-4362.2003.01682.x","volume":"42","author":"MJ Birnkrant","year":"2003","unstructured":"Birnkrant MJ, Papadopoulos AJ, Schwartz RA, Lambert WC (2003) Pyoderma Gangrenosum, acne conglobata, and IgA gammopathy. Int J Dermatol 42(3):213\u2013216","journal-title":"Int J Dermatol"},{"issue":"6","key":"3098_CR3","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jaad.2019.09.032","volume":"82","author":"CM Montagnon","year":"2020","unstructured":"Montagnon CM, Fracica EA, Patel AA, Camilleri MJ, Murad MH, Dingli D et al (2020) Pyoderma Gangrenosum in hematologic malignancies: a systematic review. J Am Acad Dermatol 82(6):1346\u20131359","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3098_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/jamadermatol.2021.5001","volume":"158","author":"YL Hou","year":"2022","unstructured":"Hou YL, Lee CH (2022) Pyoderma Gangrenosum. JAMA Dermatol 158(2):202","journal-title":"JAMA Dermatol"},{"issue":"3","key":"3098_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","volume":"18","author":"A Alavi","year":"2017","unstructured":"Alavi A, French LE, Davis MD, Brassard A, Kirsner RS (2017) Pyoderma Gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol 18(3):355\u2013372","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"3098_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s40257-014-0092-6","volume":"15","author":"A Alavi","year":"2014","unstructured":"Alavi A, Sajic D, Cerci FB, Ghazarian D, Rosenbach M, Jorizzo J (2014) Neutrophilic dermatoses: an update. Am J Clin Dermatol 15(5):413\u2013423","journal-title":"Am J Clin Dermatol"},{"key":"3098_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/978-1-4614-3764-2_29","volume-title":"Neoplastic diseases of the blood","author":"J Katzmann","year":"2013","unstructured":"Katzmann J, Kyle RA, Lust J, Snyder M, Dispenzieri A (2013) Immunoglobulins and Laboratory Recognition of Monoclonal Proteins. In: Wiernik PH, Goldman JM, Dutcher JP, Kyle RA (eds) Neoplastic diseases of the blood. Springer New York, New York, NY, pp 565\u2013588"},{"issue":"11","key":"3098_CR8","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.clml.2017.06.022","volume":"17","author":"MV Mateos","year":"2017","unstructured":"Mateos MV, Gonzalez-Calle V (2017) Smoldering multiple myeloma: who and when to treat. Clin Lymphoma Myeloma Leuk 17(11):716\u2013722","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3098_CR9","unstructured":"Kaseb H, Annamaraju P, Babiker HM (2023) Monoclonal gammopathy of undetermined significance. StatPearls. Treasure Island (FL)"},{"issue":"10","key":"3098_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4065\/mcp.2010.0337","volume":"85","author":"RK Wadhera","year":"2010","unstructured":"Wadhera RK, Rajkumar SV (2010) Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc 85(10):933\u2013942","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"3098_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/archderm.1983.01650300022009","volume":"119","author":"FC Powell","year":"1983","unstructured":"Powell FC, Schroeter AL, Su WP, Perry HO (1983) Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol 119(6):468\u2013472","journal-title":"Arch Dermatol"},{"issue":"4","key":"3098_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0190-9622(99)70434-2","volume":"40","author":"MS Daoud","year":"1999","unstructured":"Daoud MS, Lust JA, Kyle RA, Pittelkow MR (1999) Monoclonal gammopathies and associated skin disorders. J Am Acad Dermatol 40(4):507\u2013535 quiz 36\u2009\u2013\u20098","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3098_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1046\/j.1365-2133.2001.04450.x","volume":"145","author":"TA Chave","year":"2001","unstructured":"Chave TA, Hutchinson PE (2001) Pyoderma Gangrenosum, subcorneal pustular dermatosis, IgA paraproteinaemia and IgG antiepithelial antibodies. Br J Dermatol 145(5):852\u2013854","journal-title":"Br J Dermatol"},{"issue":"5","key":"3098_CR14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaad.2015.07.031","volume":"73","author":"R Szalat","year":"2015","unstructured":"Szalat R, Monsel G, Le Goff W, Battistella M, Bengouffa D, Schlageter MH et al (2015) The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile. J Am Acad Dermatol 73(5):809\u2013820","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3098_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/jdv.13847","volume":"31","author":"D Lipsker","year":"2017","unstructured":"Lipsker D (2017) Monoclonal gammopathy of cutaneous significance: review of a relevant concept. J Eur Acad Dermatol Venereol 31(1):45\u201352","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"3098_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41408-022-00661-1","volume":"12","author":"JS Claveau","year":"2022","unstructured":"Claveau JS, Wetter DA, Kumar S (2022) Cutaneous manifestations of monoclonal gammopathy. Blood Cancer J 12(4):58","journal-title":"Blood Cancer J"},{"issue":"8","key":"3098_CR17","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1111\/ijd.14841","volume":"59","author":"KP Hoffman","year":"2020","unstructured":"Hoffman KP, Shearer S, Chung C, Kaffenberger JA, Kaffenberger BH (2020) Clinical and therapeutic overlap of pyoderma gangrenosum, cutaneous small vessel vasculitis, and immunoglobulin A. Int J Dermatol 59(8):e286\u2013e8","journal-title":"Int J Dermatol"},{"key":"3098_CR18","doi-asserted-by":"crossref","unstructured":"Machan A, Azendour H, Frikh R, Hjira N, Boui M (2020) The dilemma of treating pyoderma gangrenosum associated with monoclonal gammopathy of undetermined significance. Dermatol Online J. 26(5)","DOI":"10.5070\/D3265048791"},{"issue":"6","key":"3098_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","volume":"134","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Rajkumar SV (2006) Monoclonal gammopathy of undetermined significance. Br J Haematol 134(6):573\u2013589","journal-title":"Br J Haematol"},{"issue":"16","key":"3098_CR20","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1182\/blood-2013-10-532283","volume":"123","author":"N Weinhold","year":"2014","unstructured":"Weinhold N, Johnson DC, Rawstron AC, Forsti A, Doughty C, Vijayakrishnan J et al (2014) Inherited genetic susceptibility to monoclonal gammopathy of unknown significance. Blood 123(16):2513\u20132517 quiz 93","journal-title":"Blood"},{"issue":"1","key":"3098_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hon.2548","volume":"37","author":"L Ma","year":"2019","unstructured":"Ma L, Xu S, Qu J, Hou J, Wang Y, Wen L et al (2019) Monoclonal gammopathy of undetermined significance in Chinese population: a prospective epidemiological study. Hematol Oncol 37(1):75\u201379","journal-title":"Hematol Oncol"},{"issue":"13","key":"3098_CR22","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR et al (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354(13):1362\u20131369","journal-title":"N Engl J Med"},{"issue":"7","key":"3098_CR23","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3109\/10428194.2015.1113277","volume":"57","author":"Y Lecluse","year":"2016","unstructured":"Lecluse Y, Comby E, Mariotte D, Tual S, Le Mauff B, Lebailly P et al (2016) Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among farmers involved in open field farming and\/or cattle breading in France. Leuk Lymphoma 57(7):1727\u20131730","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"3098_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.canep.2014.04.006","volume":"38","author":"Q Cabrera","year":"2014","unstructured":"Cabrera Q, Macro M, Hebert B, Cornet E, Collignon A, Troussard X (2014) Epidemiology of Monoclonal Gammopathy of undetermined significance (MGUS): the experience from the specialized registry of hematologic malignancies of Basse-Normandie (France). Cancer Epidemiol 38(4):354\u2013356","journal-title":"Cancer Epidemiol"},{"issue":"12","key":"3098_CR25","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","volume":"82","author":"M Iwanaga","year":"2007","unstructured":"Iwanaga M, Tagawa M, Tsukasaki K, Kamihira S, Tomonaga M (2007) Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan. Mayo Clin Proc 82(12):1474\u20131479","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"3098_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.beha.2005.01.025","volume":"18","author":"RA Kyle","year":"2005","unstructured":"Kyle RA, Rajkumar SV (2005) Monoclonal gammopathies of undetermined significance. Best Pract Res Clin Haematol 18(4):689\u2013707","journal-title":"Best Pract Res Clin Haematol"},{"issue":"7","key":"3098_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00277-002-0493-0","volume":"81","author":"A Anagnostopoulos","year":"2002","unstructured":"Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA (2002) Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece. Ann Hematol 81(7):357\u2013361","journal-title":"Ann Hematol"},{"issue":"5","key":"3098_CR28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","volume":"104","author":"HJ Cohen","year":"1998","unstructured":"Cohen HJ, Crawford J, Rao MK, Pieper CF, Currie MS (1998) Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J Med 104(5):439\u2013444","journal-title":"Am J Med"},{"issue":"2","key":"3098_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5114\/pdia.2014.40974","volume":"32","author":"K Romanska-Gocka","year":"2015","unstructured":"Romanska-Gocka K, Ciescinska C, Zegarska B, Schwartz RA, Ciescinski J, Olszewska-Slonina D et al (2015) Pyoderma gangrenosum with monoclonal IgA gammopathy and pulmonary tuberculosis. Illustrative case and review. Postepy Dermatol Alergol 32(2):137\u2013141","journal-title":"Postepy Dermatol Alergol"},{"issue":"6","key":"3098_CR30","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/iwj.12746","volume":"14","author":"V Velasco-Tamariz","year":"2017","unstructured":"Velasco-Tamariz V, Carreno-Tarragona G, Tous-Romero F, Gil-de la Cruz E, Martin-Clavero E, Rivera-Diaz R (2017) Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone. Int Wound J 14(6):1382\u20131384","journal-title":"Int Wound J"},{"issue":"8","key":"3098_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00277-009-0880-x","volume":"89","author":"CM Chang","year":"2010","unstructured":"Chang CM, Hwang WL, Hsieh ZY, Wang RC, Teng CL (2010) Monoclonal gammopathy of undetermined significance related pyoderma gangrenosum successfully treated with autologous peripheral blood stem cell transplantation. Ann Hematol 89(8):823\u2013824","journal-title":"Ann Hematol"},{"issue":"6","key":"3098_CR32","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","volume":"165","author":"AM Binus","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165(6):1244\u20131250","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03098-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03098-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03098-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:35:16Z","timestamp":1719401716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03098-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3098"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03098-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,25]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was deemed exempt by the Mayo Clinic Institutional Review Board (22-009857).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Only patients who signed consent to be enrolled in research are included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"from identifiable patients: Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"268"}}